Results 91 to 100 of about 412,643 (184)

Similar Pharmacokinetics and Pharmacodynamics of Biosimilar SAR342434 Insulin Lispro and Japan-Approved Humalog Insulin Lispro in Healthy Japanese Subjects. [PDF]

Clin Pharmacol Drug Dev, 2022
Shiramoto M, Yoshihara T, Schmider W, Takahashi Y, Nowotny I, Kajiwara M, Muto H.   +6 more
europepmc   +1 more source

Efficacy of insulin lispro in pregnancies complicated with pregestational diabetes mellitus

, 2009
Insulin is the mainstay in the management of pregnancies complicated by pregestational diabetes. Insulin analogues are useful in the non-pregnant state, leading to better glycaemic control.
Hughes, S. M., Banerjee, M.; id_orcid, Bhattacharya, A., Vice, P. A.   +3 more
core   +1 more source

New Injection Site Dynamics of Insulin Lispro Discovered Through Photoacoustic Imaging. [PDF]

J Diabetes Sci Technol, 2023
Jain AK.
europepmc   +1 more source

Diyabetli hastaların tedavisinde insulin lispro ile regüler insan insulinin karşılaştırılması

, 2003
Amaç: Diyabetli hastalarda yoğun insulin tedavisinde insulin Lispro ile reguler insan insulininin glisemik kontrol ve hipoglisemi sıklığı üzerine olan etkilerini karşılaştırmayı amaçladık.

core  

Insulin lispro: a potential role in preventing nocturnal hypoglycaemia in young children with diabetes mellitus.

, 2003
AIMS: The long duration of action of soluble insulin given in the evening could contribute to the high prevalence of nocturnal hypoglycaemia seen in young children with Type 1 diabetes mellitus (T1DM).
Ford-Adams, ME, Dunger, DB, Ong, KL, Watts, AP, Murphy, NP, Moore, EJ, Edge, JA, Acerini, CL   +7 more
core   +1 more source

Comparison of Efficacy and Safety of Lispro and Aspart Evaluated by Continuous Glucose Monitoring System in Patients with Newly Diagnosed Type 2 Diabetes

International Journal of Endocrinology, 2018
Objective. To compare the effect of the rapid-acting insulin analogues (RAIAs) aspart (NovoRapid) and lispro (Prandilin) on glycemic variations by continuous glucose monitoring system (CGMS) in patients within newly diagnosed type 2 diabetes mellitus ...
Bing-li Liu, Guo-ping Yin, Feng-fei Li, Yun Hu, Jin-dan Wu, Mao-yuan Chen, Lei Ye, Xiao-fei Su, Jian-hua Ma   +8 more
doaj   +1 more source

Evaluation of Insulin Lispro Pharmacokinetics and Pharmacodynamics Over 10 Days of Continuous Insulin Infusion in People With Type 1 Diabetes. [PDF]

J Diabetes Sci Technol, 2023
Garhyan P, Pratt E, Klein O, Famulla S, Zijlstra E, Lalonde A, Swinney M, Kazda C, Dassau E.   +8 more
europepmc   +1 more source

Symptomatic and physiological responses to hypoglycaemia induced by human soluble insulin and the analogue Lispro human insulin

, 1997
The aim of this study was to compare the glycaemic threshold for onset of the clinically detectable sympatho-adrenal (autonomic) reaction (defined as 'R') to hypoglycaemia induced by Lispro human insulin, with that induced by human soluble insulin (HS ...
Lusty, J., Frier, B. M., Dunstan, Frank David John, Diem, P, Davey Smith, G, Young, S., Stettler, C, Egger, M, George, L. D., Leverton, C., McCrimmon, R. J.; id_orcid, Owens, David Raymond   +11 more
core   +1 more source

Profile of Patients with Diabetes Treated with Insulin Lispro 200 U/ml: A Real-World Study from Spain. [PDF]

Diabetes Ther, 2022
Rubio de Santos M, Artime E, Duque N, Díaz-Cerezo S, Spaepen E, Carreño Á, Fernández A.   +6 more
europepmc   +1 more source

Better postprandial glucose stability during continuous subcutaneous infusion with insulin aspart compared with insulin lispro in patients with type 1 diabetes

, 2008
Background: Persistent glucose variability is a frequent condition in type 1 diabetes. Continuous subcutaneous insulin infusion (CSII) is a rational option to overcome this clinical issue; however, no comparative studies have been reported for aspart and
Scaramuzza A., Pellicano F., Cannata F., Fabbri T., Brandolini S., Casetti T., Meandri P., Sardu C., Di Bartolo P., Bosi E., Miselli V.   +10 more
core   +1 more source